CHE Financials Chemed Corp

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Nov 1, 2026, 10:30 UTC Overview →

Growth & profitability

Revenue has grown 4.0% per year over the past 5 years.
Net income has grown slower than revenue (-75.8% vs 4.0% per year).
Operating margin has contracted, at 13.4% in the latest year.
Free cash flow has declined 5.4% per year over the past 5 years.

Financial health

Total debt has grown slower than revenue (-0.7% vs 4.0% per year).
Operating income covered interest expense 193× in the latest year, up from 165× 5 years ago.

Shareholder returns

Dividends have been paid for 15 consecutive years, consuming 11949.6% of earnings and 9.7% of free cash flow.
The dividend has grown 8.5% per year over the past 5 years.

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key annual figures

FY	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
2025	$2.5B	$265238	32.5%	13.4%	0.0%	0.0%	$325M	—	$75M
2024	$2.4B	$301999	35.1%	15.1%	0.0%	0.0%	$368M	—	$178M
2023	$2.3B	$272509	35.3%	15.0%	0.0%	0.0%	$273M	—	$264M
2022	$2.1B	$249624	35.8%	16.1%	0.0%	0.0%	$253M	$98M	$74M
2021	$2.1B	$268550	36.0%	16.0%	0.0%	0.0%	$250M	$185M	$33M
2020	$2.1B	$319M	33.7%	18.7%	35.4%	22.3%	$430M	—	$163M
2019	$1.9B	$220M	31.8%	13.3%	30.3%	17.3%	$248M	$90M	$6M
2018	$1.8B	$206M	31.1%	13.7%	34.8%	21.1%	$234M	$89M	$5M
2017	$1.7B	$98M	31.0%	6.8%	18.2%	10.7%	$98M	$101M	$11M
2016	$1.6B	$109M	29.3%	11.3%	20.7%	12.4%	$96M	$109M	$15M
2015	—	$110M	—	—	21.5%	12.9%	$127M	$91M	$15M
2014	—	$99M	—	—	22.0%	11.5%	—	$148M	$14M
2013	—	$77M	—	—	17.2%	8.6%	—	$184M	$84M
2012	—	$89M	—	—	19.7%	10.4%	$97M	$175M	$70M
2011	—	$86M	—	—	20.8%	10.8%	$145M	$167M	$38M

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex, quarterly)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key quarterly figures

Quarter	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
Sep '26	$691M	$72M	33.7%	14.0%	8.3%	4.2%	$38M	$236M	$48M
Jun '26	$673M	$68M	32.9%	13.2%	8.2%	4.3%	$69M	$140M	$40M
Mar '26	$658M	$66M	32.8%	12.9%	7.8%	4.3%	$71M	$91M	$17M
Dec '25	$639M	$77M	35.2%	15.7%	7.8%	5.0%	$117M	—	$75M
Sep '25	$625M	$64M	32.0%	12.0%	6.0%	4.0%	$66M	—	$130M
Jun '25	$619M	$52M	29.8%	11.0%	4.4%	3.1%	$123M	—	$250M
Mar '25	$647M	$72M	33.5%	14.6%	6.1%	4.2%	$19M	—	$174M
Dec '24	$640M	$90M	36.6%	17.8%	8.1%	5.4%	$152M	—	$178M
Sep '24	$606M	$76M	34.6%	15.2%	6.1%	4.3%	$77M	—	$238M
Jun '24	$596M	$71M	34.6%	14.8%	5.9%	4.1%	$66M	—	$223M
Mar '24	$589M	$65M	34.6%	12.3%	5.5%	3.8%	$72M	—	$313M
Dec '23	$586M	$90M	38.8%	19.0%	8.1%	5.4%	$97M	—	$264M
Sep '23	$565M	$75M	35.8%	15.4%	7.4%	4.8%	$17M	—	$173M
Jun '23	$554M	$53M	32.4%	12.6%	5.6%	3.5%	$116M	—	$160M
Mar '23	$560M	$54M	33.8%	13.0%	6.1%	3.8%	$43M	$21M	$58M
Dec '22	$547M	$62M	36.1%	14.9%	7.8%	4.3%	$82M	$98M	$74M
Sep '22	$526M	$57M	34.1%	15.4%	7.9%	4.2%	$39M	$101M	$8M
Jun '22	$531M	$66M	36.6%	17.3%	9.7%	5.1%	$44M	$117M	$10M
Mar '22	$531M	$64M	36.6%	16.8%	9.6%	4.9%	$88M	$120M	$18M
Dec '21	$541M	$75M	37.8%	18.1%	12.0%	5.6%	$49M	$185M	$33M

Valuation over time

How the market has priced CHE against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

The price-to-earnings ratio has fallen from 28083.1× (Mar '23) to 26626.7× (Nov '26).
The price-to-sales ratio has fallen from 3.3× (Mar '23) to 2.8× (Nov '26).
The dividend yield has risen from 0.3% (Mar '23) to 0.4% (Nov '26).

Price / earnings (P/E)

P/E

Price / sales (P/S)

P/S

Dividend yield (%)

Dividend yield %

Frequently asked questions

Is CHE growing its revenue and profit?

Over the past 5 years, Chemed Corp's revenue has grown 4.0% per year, and net income declined 75.8% per year. These are computed facts, not advice.

How much debt does CHE have?

As of FY2025, Chemed Corp reported — of total debt against $75M of cash; operating income covered interest expense 193×.

What is CHE's profit margin?

In FY2025, gross margin was 32.5%, operating margin 13.4%, and net margin 0.0%.

What is CHE's P/E ratio?

Chemed Corp's P/E (TTM) is 25.01 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the CHE stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 26626.7× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.